Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katelyn L Donahue

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Investigation|February 15, 2022
Cleaved CDCP1 marks the spot: a neoepitope for RAS-driven cancersKatelyn L Donahue, Marina Pasca di Magliano
ACS Pharmacology & Translational Science|April 8, 2020
Differential Sensitivity to CDK2 Inhibition Discriminates the Molecular Mechanisms of CHK1 Inhibitors as Monotherapy or in Combination with the Topoisomerase I Inhibitor SN38Nicholas J H Warren, Katelyn L Donahue, Alan Eastman
Scientific Reports|March 30, 2021
Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunctionJennifer P Ditano, Katelyn L Donahue, Laura J Tafe, et al.
JCI Insight|July 8, 2026
Unleashing innovative cross-organ fibrosis therapies by harnessing the omics revolutionCynthia Lebeaupin, Katelyn L Donahue, Ken Dower, et al.
The Journal of Eukaryotic Microbiology|August 24, 2018
Using the SSU, ITS, and Ribosomal DNA Operon Arrangement to Characterize Two Microsporidia Infecting Bruce Spanworm, Operophtera bruceata (Lepidoptera: Geometridae)Katelyn L Donahue, Hannah J Broadley, Joseph S Elkinton, et al.
Oncogenesis|September 15, 2022
Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic cancerAshley M Mello, Tenzin Ngodup, Yusoo Lee, et al.
Molecular Cancer Research : MCR|February 20, 2025
SMURF2 Facilitates GAP17 Isoform 1 Membrane Displacement to Promote Mutant p53-KRAS Oncogenic SynergyParamita Ray, Shirish Shukla, Yaqing Zhang, et al.
The Journal of Experimental Medicine|October 14, 2022
WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancerWenting Du, Rosa E Menjivar, Katelyn L Donahue, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Notch signaling regulates immunosuppressive tumor-associated macrophage function in pancreatic cancerWei Yan, Nina G Steele, Samantha B Kemp, et al.
Cancer Immunology Research|November 6, 2023
Notch Signaling Regulates Immunosuppressive Tumor-Associated Macrophage Function in Pancreatic CancerWei Yan, Rosa E Menjivar, Monica E Bonilla, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Investigation|February 15, 2022
Cleaved CDCP1 marks the spot: a neoepitope for RAS-driven cancersKatelyn L Donahue, Marina Pasca di Magliano
ACS Pharmacology & Translational Science|April 8, 2020
Differential Sensitivity to CDK2 Inhibition Discriminates the Molecular Mechanisms of CHK1 Inhibitors as Monotherapy or in Combination with the Topoisomerase I Inhibitor SN38Nicholas J H Warren, Katelyn L Donahue, Alan Eastman
Scientific Reports|March 30, 2021
Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunctionJennifer P Ditano, Katelyn L Donahue, Laura J Tafe, et al.
JCI Insight|July 8, 2026
Unleashing innovative cross-organ fibrosis therapies by harnessing the omics revolutionCynthia Lebeaupin, Katelyn L Donahue, Ken Dower, et al.
The Journal of Eukaryotic Microbiology|August 24, 2018
Using the SSU, ITS, and Ribosomal DNA Operon Arrangement to Characterize Two Microsporidia Infecting Bruce Spanworm, Operophtera bruceata (Lepidoptera: Geometridae)Katelyn L Donahue, Hannah J Broadley, Joseph S Elkinton, et al.
Oncogenesis|September 15, 2022
Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic cancerAshley M Mello, Tenzin Ngodup, Yusoo Lee, et al.
Molecular Cancer Research : MCR|February 20, 2025
SMURF2 Facilitates GAP17 Isoform 1 Membrane Displacement to Promote Mutant p53-KRAS Oncogenic SynergyParamita Ray, Shirish Shukla, Yaqing Zhang, et al.
The Journal of Experimental Medicine|October 14, 2022
WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancerWenting Du, Rosa E Menjivar, Katelyn L Donahue, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Notch signaling regulates immunosuppressive tumor-associated macrophage function in pancreatic cancerWei Yan, Nina G Steele, Samantha B Kemp, et al.
Cancer Immunology Research|November 6, 2023
Notch Signaling Regulates Immunosuppressive Tumor-Associated Macrophage Function in Pancreatic CancerWei Yan, Rosa E Menjivar, Monica E Bonilla, et al.
Pageof 3